December 27, 2023
2 min watch
Save
VIDEO: New treatments require new dosing strategies
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Jean-François Korobelnik, MD, PhD, reflects on how retina specialists are going to use Eylea HD in real-world practice.
“We have to think about strategies besides the results of the randomized clinical trials,” he said, posing a few questions that will be answered with clinical experience.
Editor's note: This article was updated on Jan. 2, 2024, to add the brand name for Eylea HD.
Published by:
Sources/Disclosures
Collapse
Source:
Korobelnik JF. New strategies for new treatments in AMD. Presented at: FLORetina-ICOOR; Nov. 30-Dec. 3, 2023; Rome.
Disclosures:
Korobelnik reports consulting for Bayer and Roche.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.